{"transactions":[{"id":4640972,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-10-15T21:35:03.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001193125-26-423056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000119312526423056/ownership.xml","form_type":"4"}},{"id":4640971,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-15T21:35:03.000Z","date":"2026-10-14","kind":"sale","planned":false,"acquired":false,"shares":4098,"price":49.26,"value":201867.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":259736,"source":{"system":"sec-edgar","filing":"0001193125-26-423056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000119312526423056/ownership.xml","form_type":"4"}},{"id":4640970,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-15T21:35:03.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":263834,"source":{"system":"sec-edgar","filing":"0001193125-26-423056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000119312526423056/ownership.xml","form_type":"4"}},{"id":4638097,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-08T21:35:03.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":1990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% shall vest on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months."}],"balance_after":81242,"derivative":{"exercise_price":13.62,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":1990},"source":{"system":"sec-edgar","filing":"0001193125-26-418101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526418101/ownership.xml","form_type":"4"}},{"id":4638096,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-10-08T21:35:03.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":1990,"price":60.0408,"value":119481.192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":94784,"source":{"system":"sec-edgar","filing":"0001193125-26-418101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526418101/ownership.xml","form_type":"4"}},{"id":4638095,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-10-08T21:35:03.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":1990,"price":13.62,"value":27103.8,"ownership":{"direct":true},"balance_after":96774,"source":{"system":"sec-edgar","filing":"0001193125-26-418101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526418101/ownership.xml","form_type":"4"}},{"id":4626361,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T21:35:13.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":false,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% shall vest on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months."}],"balance_after":83232,"derivative":{"exercise_price":13.62,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001193125-26-401237","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526401237/ownership.xml","form_type":"4"}},{"id":4626360,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-09-24T21:35:13.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":10400,"price":60.2365,"value":626459.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":94784,"source":{"system":"sec-edgar","filing":"0001193125-26-401237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526401237/ownership.xml","form_type":"4"}},{"id":4626359,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-09-24T21:35:13.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":true,"shares":10400,"price":13.62,"value":141648.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 476 shares acquired under the CRISPR Therapeutics AG 2026 Employee Stock Purchase Plan."}],"balance_after":105184,"source":{"system":"sec-edgar","filing":"0001193125-26-401237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526401237/ownership.xml","form_type":"4"}},{"id":4623779,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":31983,"kind":"person","name":"Behbahani Ali","position":1,"cik":"0001613867","reported_name":"Behbahani Ali","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-21T22:40:40.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on October 18, 2016 with respect to 30,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments beginning October 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":14,"expiration_date":"2026-10-18","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-396944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526396944/ownership.xml","form_type":"4"}},{"id":4623778,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":31983,"kind":"person","name":"Behbahani Ali","position":1,"cik":"0001613867","reported_name":"Behbahani Ali","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-21T22:40:40.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":13679,"price":57.0901,"value":780935.4779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.97 to $57.43 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16637,"source":{"system":"sec-edgar","filing":"0001193125-26-396944","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526396944/ownership.xml","form_type":"4"}},{"id":4623777,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":31983,"kind":"person","name":"Behbahani Ali","position":1,"cik":"0001613867","reported_name":"Behbahani Ali","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-21T22:40:40.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":14,"value":420000.0,"ownership":{"direct":true},"balance_after":30316,"source":{"system":"sec-edgar","filing":"0001193125-26-396944","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526396944/ownership.xml","form_type":"4"}},{"id":4623749,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":31983,"kind":"person","name":"Behbahani Ali","position":1,"cik":"0001613867","reported_name":"Behbahani Ali","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-21T22:30:10.000Z","date":"2025-08-06","kind":"other","planned":false,"acquired":true,"shares":15,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Ali Behbahani Revocable Trust Dated June 26, 2015 (the \"Behbahani Trust\") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest."}],"balance_after":29,"source":{"system":"sec-edgar","filing":"0001193125-26-396935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526396935/ownership.xml","form_type":"4"}},{"id":4623748,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":31983,"kind":"person","name":"Behbahani Ali","position":1,"cik":"0001613867","reported_name":"Behbahani Ali","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-21T22:30:10.000Z","date":"2025-08-06","kind":"other","planned":false,"acquired":true,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"NEA Partners 15, L.P. (\"NEA Partners 15\") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025."}],"balance_after":316,"source":{"system":"sec-edgar","filing":"0001193125-26-396935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526396935/ownership.xml","form_type":"4"}},{"id":690739,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-11T21:35:31.000Z","date":"2026-08-07","kind":"gift","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14815,"source":{"system":"sec-edgar","filing":"0001193125-26-345111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526345111/ownership.xml","form_type":"4"}},{"id":744665,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39164,"kind":"person","name":"George Simeon","position":1,"cik":"0001595117","reported_name":"George Simeon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:09:19.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264390/ownership.xml","form_type":"4"}},{"id":744664,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":31983,"kind":"person","name":"Behbahani Ali","position":1,"cik":"0001613867","reported_name":"Behbahani Ali","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:06:29.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264382/ownership.xml","form_type":"4"}},{"id":744663,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":26160,"kind":"person","name":"Fardis Maria","position":1,"cik":"0001559231","reported_name":"Fardis Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:43:39.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264290/ownership.xml","form_type":"4"}},{"id":744662,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":36884,"kind":"person","name":"Fleming Harold Edward","position":1,"cik":"0001857250","reported_name":"Fleming Harold Edward","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:43:22.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264289","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264289/ownership.xml","form_type":"4"}},{"id":744661,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40058,"kind":"person","name":"Greene John","position":1,"cik":"0001610732","reported_name":"Greene John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:43:01.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264288/ownership.xml","form_type":"4"}},{"id":744660,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":39853,"kind":"person","name":"High Katherine A","position":1,"cik":"0001631248","reported_name":"High Katherine A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:42:32.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264287/ownership.xml","form_type":"4"}},{"id":744659,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40057,"kind":"person","name":"Mahatme Sandesh","position":1,"cik":"0001511034","reported_name":"Mahatme Sandesh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:42:05.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264286","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264286/ownership.xml","form_type":"4"}},{"id":744658,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":35090,"kind":"person","name":"Morrison Briggs","position":1,"cik":"0001654430","reported_name":"Morrison Briggs","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:41:28.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264285","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526264285/ownership.xml","form_type":"4"}},{"id":744960,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40137,"kind":"person","name":"Rommel Christian","position":1,"cik":"0002022449","reported_name":"Rommel Christian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:41:00.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022449/000119312526264282/ownership.xml","form_type":"4"}},{"id":744677,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":40063,"kind":"person","name":"Treco Douglas A","position":1,"cik":"0001688192","reported_name":"Treco Douglas A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T21:40:32.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on June 30, 2026 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2027 Annual Meeting."}],"balance_after":13000,"derivative":{"exercise_price":51.84,"expiration_date":"2036-06-05","underlying":"Common Shares","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001193125-26-264279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688192/000119312526264279/ownership.xml","form_type":"4"}},{"id":754778,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-06-02T21:42:26.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 17,000 Common Shares, with 100% of the shares vesting on November 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 17,000 Common Shares, with 100% of the shares vesting on November 29, 2028."}],"balance_after":17000,"derivative":{"underlying":"Common Shares","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001193125-26-253929","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526253929/ownership.xml","form_type":"4"}},{"id":755260,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-02T21:41:55.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 22,000 Common Shares, with 100% of the shares vesting on November 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 22,000 Common Shares, with 100% of the shares vesting on November 29, 2028."}],"balance_after":22000,"derivative":{"underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001193125-26-253926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526253926/ownership.xml","form_type":"4"}},{"id":754776,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-02T21:41:26.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 19,500 Common Shares, with 100% of the shares vesting on November 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 19,500 Common Shares, with 100% of the shares vesting on November 29, 2028."}],"balance_after":19500,"derivative":{"underlying":"Common Shares","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001193125-26-253925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526253925/ownership.xml","form_type":"4"}},{"id":757358,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-01T21:35:40.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-251817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526251817/ownership.xml","form_type":"4"}},{"id":757357,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-06-01T21:35:40.000Z","date":"2026-05-29","kind":"sale","planned":false,"acquired":false,"shares":3786,"price":55.62,"value":210577.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":19357,"source":{"system":"sec-edgar","filing":"0001193125-26-251817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526251817/ownership.xml","form_type":"4"}},{"id":757356,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-06-01T21:35:40.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":23143,"source":{"system":"sec-edgar","filing":"0001193125-26-251817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526251817/ownership.xml","form_type":"4"}},{"id":829320,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":12000,"derivative":{"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829319,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":25000,"derivative":{"underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829318,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":38499,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":38499},"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829317,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":3182,"price":46.78,"value":148853.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":94308,"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829316,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":97490,"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829315,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":19687,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":39375,"derivative":{"underlying":"Common Shares","underlying_shares":19687},"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829314,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":81875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":81875,"derivative":{"underlying":"Common Shares","underlying_shares":81875},"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829313,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":114249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 20, 2026 with respect to 114,249 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":114249,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":114249},"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829312,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":10020,"price":46.78,"value":468735.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":255501,"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829311,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":19687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":265521,"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829306,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":12500,"derivative":{"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829305,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":27500,"derivative":{"underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829304,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":38499,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":38499},"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829303,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":3708,"price":46.78,"value":173460.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":15565,"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829302,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":19273,"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829534,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:36:41.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 30,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 30,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":30000,"derivative":{"underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-122267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526122267/ownership.xml","form_type":"4"}},{"id":829533,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:36:41.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":38499,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":38499},"source":{"system":"sec-edgar","filing":"0001193125-26-122267","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526122267/ownership.xml","form_type":"4"}},{"id":838575,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:37:40.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":24375,"derivative":{"underlying":"Common Shares","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001193125-26-111286","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526111286/ownership.xml","form_type":"4"}},{"id":838574,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:40.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3150,"price":48.26,"value":152019.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":13143,"source":{"system":"sec-edgar","filing":"0001193125-26-111286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526111286/ownership.xml","form_type":"4"}},{"id":838573,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:40.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":8125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 592 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":16293,"source":{"system":"sec-edgar","filing":"0001193125-26-111286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526111286/ownership.xml","form_type":"4"}},{"id":837956,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":20625,"derivative":{"underlying":"Common Shares","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837955,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."}],"balance_after":10000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837954,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-16","kind":"gift","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Reporting person remains subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. Transfers of lock-up securities as a bona fide gift are permitted. No consideration was received by the reporting person in connection with such transfer."}],"balance_after":13023,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837953,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":4021,"price":48.26,"value":194053.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":13773,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837952,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":5848,"price":48.26,"value":282224.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":17794,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837951,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":23642,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837950,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":16767,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837949,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:35:54.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":20625,"derivative":{"underlying":"Common Shares","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001193125-26-111281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111281/ownership.xml","form_type":"4"}},{"id":837948,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:54.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3450,"price":48.26,"value":166497.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":91240,"source":{"system":"sec-edgar","filing":"0001193125-26-111281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111281/ownership.xml","form_type":"4"}},{"id":837947,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:54.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":94690,"source":{"system":"sec-edgar","filing":"0001193125-26-111281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111281/ownership.xml","form_type":"4"}},{"id":837946,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:35:20.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":20625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":61875,"derivative":{"underlying":"Common Shares","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0001193125-26-111278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111278/ownership.xml","form_type":"4"}},{"id":837945,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:20.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":10349,"price":48.26,"value":499442.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":245834,"source":{"system":"sec-edgar","filing":"0001193125-26-111278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111278/ownership.xml","form_type":"4"}},{"id":837944,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:20.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":20625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":256183,"source":{"system":"sec-edgar","filing":"0001193125-26-111278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111278/ownership.xml","form_type":"4"}},{"id":846105,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T21:35:06.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":5500,"derivative":{"underlying":"Common Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001193125-26-104481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104481/ownership.xml","form_type":"4"}},{"id":846104,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:06.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":52.8,"value":147840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":87815,"source":{"system":"sec-edgar","filing":"0001193125-26-104481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104481/ownership.xml","form_type":"4"}},{"id":846103,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:06.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":90615,"source":{"system":"sec-edgar","filing":"0001193125-26-104481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104481/ownership.xml","form_type":"4"}},{"id":846102,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T21:35:04.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":19250,"derivative":{"underlying":"Common Shares","underlying_shares":19250},"source":{"system":"sec-edgar","filing":"0001193125-26-104480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104480/ownership.xml","form_type":"4"}},{"id":846101,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:04.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":9798,"price":52.8,"value":517334.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":235558,"source":{"system":"sec-edgar","filing":"0001193125-26-104480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104480/ownership.xml","form_type":"4"}},{"id":846100,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:04.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":245356,"source":{"system":"sec-edgar","filing":"0001193125-26-104480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104480/ownership.xml","form_type":"4"}},{"id":890703,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-20T22:36:52.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0001193125-26-061712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061712/ownership.xml","form_type":"4"}},{"id":890702,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-20T22:36:52.000Z","date":"2026-02-19","kind":"sale","planned":false,"acquired":false,"shares":6967,"price":52.58,"value":366324.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":226106,"source":{"system":"sec-edgar","filing":"0001193125-26-061712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061712/ownership.xml","form_type":"4"}},{"id":890701,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-20T22:36:52.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 85,622 shares previously transferred from the Kulkarni 2023 GRAT to the Reporting Person."}],"balance_after":233073,"source":{"system":"sec-edgar","filing":"0001193125-26-061712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061712/ownership.xml","form_type":"4"}},{"id":890700,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-02-20T22:35:43.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0001193125-26-061710","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061710/ownership.xml","form_type":"4"}},{"id":890699,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-02-20T22:35:43.000Z","date":"2026-02-19","kind":"sale","planned":false,"acquired":false,"shares":2112,"price":52.58,"value":111048.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":85115,"source":{"system":"sec-edgar","filing":"0001193125-26-061710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061710/ownership.xml","form_type":"4"}},{"id":890698,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-02-20T22:35:43.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":87227,"source":{"system":"sec-edgar","filing":"0001193125-26-061710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061710/ownership.xml","form_type":"4"}},{"id":930161,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42475,"kind":"person","name":"Patel Naimish","position":1,"cik":"0002021679","reported_name":"Patel Naimish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares","published_at":"2026-01-27T22:35:15.000Z","date":"2025-04-03","kind":"purchase","planned":false,"acquired":true,"shares":1508,"price":32.96,"value":49703.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchase of Common Shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,508 shares, with a subsequent sale of Common Shares at a price of $35.94 per share on May 29, 2025 pursuant to a mandatory \"sell to cover\" provision in an award agreement covering a restricted stock unit that vested on such date (and which was reported on a separate Form 4 filing dated May 30, 2025). The Reporting Person has agreed to pay to the Issuer $4,493.84, representing the full amount of the profit realized in connection with the short-swing transaction."}],"balance_after":1508,"source":{"system":"sec-edgar","filing":"0001193125-26-024955","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021679/000119312526024955/ownership.xml","form_type":"4"}},{"id":931171,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T22:35:27.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":false,"shares":34972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":41667,"derivative":{"exercise_price":45.15,"expiration_date":"2033-03-14","underlying":"Common Shares","underlying_shares":34972},"source":{"system":"sec-edgar","filing":"0001193125-26-022845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526022845/ownership.xml","form_type":"4"}},{"id":931170,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-26T22:35:27.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":34972,"price":60.19,"value":2104964.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001193125-26-022845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526022845/ownership.xml","form_type":"4"}},{"id":931169,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-26T22:35:27.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":true,"shares":34972,"price":45.15,"value":1578985.8,"ownership":{"direct":true},"balance_after":41739,"source":{"system":"sec-edgar","filing":"0001193125-26-022845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526022845/ownership.xml","form_type":"4"}},{"id":933413,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-22T22:55:02.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":60.23,"value":3613800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.61, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":134201,"source":{"system":"sec-edgar","filing":"0001193125-26-019733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526019733/ownership.xml","form_type":"4"}},{"id":933412,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-22T22:55:02.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":8567,"price":52.1,"value":446340.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.45 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":194201,"source":{"system":"sec-edgar","filing":"0001193125-26-019733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526019733/ownership.xml","form_type":"4"}},{"id":933411,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-22T22:55:02.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":21433,"price":51.61,"value":1106157.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.99, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":202768,"source":{"system":"sec-edgar","filing":"0001193125-26-019733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526019733/ownership.xml","form_type":"4"}},{"id":943238,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":6339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 13, 2023 with respect to 13,832 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023."}],"balance_after":7493,"derivative":{"exercise_price":44.31,"expiration_date":"2033-10-13","underlying":"Common Shares","underlying_shares":6339},"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943237,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":23361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":76639,"derivative":{"exercise_price":45.15,"expiration_date":"2033-03-14","underlying":"Common Shares","underlying_shares":23361},"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943236,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":5763,"price":60.2134,"value":347009.8242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0000 to $60.4800, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943235,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":5004,"price":60,"value":300240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":12530,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943234,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":18933,"price":60.1799,"value":1139386.0467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0000 to $60.7300, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":17534,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943233,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":6339,"price":44.31,"value":280881.09,"ownership":{"direct":true},"balance_after":36467,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943232,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":23361,"price":45.15,"value":1054749.15,"ownership":{"direct":true},"balance_after":30128,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":959659,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-12-23T22:33:23.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":56.8858,"value":56885.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.8200 to $56.9900, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001193125-25-331162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525331162/ownership.xml","form_type":"4"}},{"id":959658,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-12-23T22:33:23.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":5472,"price":56.3345,"value":308262.384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.7800 to $56.7700, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":7767,"source":{"system":"sec-edgar","filing":"0001193125-25-331162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525331162/ownership.xml","form_type":"4"}},{"id":959657,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-12-23T22:33:23.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":3528,"price":55.1022,"value":194400.5616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.7100 to $55.7050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":13239,"source":{"system":"sec-edgar","filing":"0001193125-25-331162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525331162/ownership.xml","form_type":"4"}},{"id":960991,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-12-22T22:35:04.000Z","date":"2025-12-18","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":224201,"source":{"system":"sec-edgar","filing":"0001193125-25-329010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525329010/ownership.xml","form_type":"4"}},{"id":1015854,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-20T21:35:03.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028."}],"balance_after":300000,"derivative":{"underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-25-243819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525243819/ownership.xml","form_type":"4"}},{"id":1015853,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-20T21:35:03.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":50895,"price":67.91,"value":3456279.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":254201,"source":{"system":"sec-edgar","filing":"0001193125-25-243819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525243819/ownership.xml","form_type":"4"}},{"id":1015852,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-20T21:35:03.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":305096,"source":{"system":"sec-edgar","filing":"0001193125-25-243819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525243819/ownership.xml","form_type":"4"}},{"id":1018463,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-15T21:35:05.000Z","date":"2025-10-13","kind":"exercise","planned":false,"acquired":false,"shares":8334,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":8333,"derivative":{"underlying":"Common Shares","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001193125-25-240438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240438/ownership.xml","form_type":"4"}},{"id":1018462,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-15T21:35:05.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":4242,"price":66.6,"value":282517.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":205096,"source":{"system":"sec-edgar","filing":"0001193125-25-240438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240438/ownership.xml","form_type":"4"}},{"id":1018461,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-15T21:35:05.000Z","date":"2025-10-13","kind":"exercise","planned":false,"acquired":true,"shares":8334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":209338,"source":{"system":"sec-edgar","filing":"0001193125-25-240438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240438/ownership.xml","form_type":"4"}}],"next_cursor":"2025-10-15T21:35:05.000000Z,1018461"}